In early 2021, Rhys Edwards received a Google alert that would transform his life, possibly hopefully for ever. The alert had been set for news about David Nutt, a professor of neuropsychopharmacology. Edwards was interested in Professor Nutts unconventional ideas as an expert in how drugs affect the mind, and particularly on the therapeutic potential of psychedelics.
If youve heard of Prof Nutt, its probably from his most infamous hour, when he was forced to resign as the Labour governments drugs tsar, in 2009. His offence was to say that illegal substances such as cannabis, ecstasy and LSD were less harmful than alcohol and tobacco, a statement he stands by to this day.
The Google alert Edwards opened contained news of a radical treatment for mental health and addiction. The treatment came with Nutts seal of approval and would be available from a private clinic in Bristol run by Canadian biotechnology company Awakn Life Sciences, to any suitable candidates in the UK.
Edwards was immediately interested and eager to know more. He has suffered from depression for most of his life, leading to suicide attempts, stays in psychiatric hospitals and episodes of shockingly brutal self-harm. He tells me hes had a go at pretty much every kind of treatment going.
The approach, which combines medication and psychotherapy delivered to outpatients over a number of weeks, shows startling potential in a field which has made little progress in many decades.
Existing antidepressants are only cleaner versions of those first developed in the 50s, according to Nutt, and there has been no revision of the standard pill a day model. Only 10 per cent of those who may benefit from alcohol intervention treatment receive help and while most stop drinking at first, three-quarters relapse within six months.
We need to do better, says Nutt. Its a maintenance model. Its protecting people from the symptoms but its not getting rid of the cause, and thats something that our new therapy may be able to do.
Ive been invited to a low-key, high-stakes meeting with Nutt, who is also Awakns chief research officer, and other experts as they launch a flagship London clinic, following success in Bristol. All are convinced that it is time to properly explore new options to tackle rising levels of depression and addiction. Nutt, 71, has devoted his career to this.
Psychedelic drugs are the most interesting and innovative developments in this field, he explains.
My own view is that theyre going to revolutionise psychiatry. I dont think theres any doubt about that. I gave a talk to the Royal College of GPs this morning, and they seemed to believe me. The message is getting out there.
As a retired lawyer who made a comfortable sum after selling a consultancy business, Rhys Edwards had plenty of time to read up on the subject from his Somerset home adjacent to the Glastonbury festival site, which he shares with his wife, 10 dogs and a few other animals.
After further research a considerable amount given its unusual nature and the 6,000 price tag he underwent treatment between December 2021 and February this year.
I was on ridiculous amounts of antidepressants, Edwards says. I was pretty stable but it was like being anaesthetised. The only thing they hadnt given me was ECT (electroconvulsive therapy). I was certainly grasping for something that might be my last chance.
He has also drastically cut back on his other medication, giving up one of two heavy duty antidepressants, almost halving the dosage of the other and drinking far less alcohol.
Im not saying Im cured. I still have bad days and I still have depressive episodes. But I can deal with them and put them into context. I feel like Ive got a good life.
But this wonder treatment is ketamine, a drug with a very dark reputation. One of the reasons that it is the first psychedelic legally available for therapeutic use is that we already know so much about it.
Although often dismissed as a horse tranquilliser or party drug, it is a widely used anaesthetic, commonly chosen for use with children and short operations such as fixing dislocated shoulders. A variation called esketamine is already available through the NHS, prescribed as a nasal spray and not offered alongside therapy, which Awakn believes is the key to long-term benefits.
This combination has unique effects on the brain circuitry associated with unhelpful thinking and behavioural patterns, Awakns website states.
It may allow you to work through issues in ways that have not been possible with therapy alone, and help you to relearn the behaviours and thought patterns that hold you back.
The company researches ketamine and MDMA (ecstasy) treatments for alcohol use disorder (AUD). Professor Celia Morgan, who made the ketamine breakthroughs and is head of Awakns ketamine-assisted therapy, runs the Ketamine for Reduction of Alcohol Relapse trial at the University of Exeter. During the Phase II trial involving 96 participants between 2016 and 2020, her findings revealed that low doses of ketamine combined with psychological therapy can help prevent relapse, showing 87 per cent abstinence at six months compared with the usual one quarter.
AUD is a prime focus given its prevalence it affects 400 million people globally but it is hoped that behavioural addictions such as gambling, food and sex may also be candidates.
Whats so exciting is it brings psychology and psychiatry back together, says Nutt.
I certainly think psychiatrists are ready for it. Im not sure about psychologists. It challenges what theyve been telling their patients for a long time that you should never take drugs. Ive had flak for even talking about these treatments.
Other psychedelics including psilocybin (magic mushrooms) and MDMA are also being trialled. There is little evidence of addiction to psychedelics but opiates such as morphine and fentanyl, which are known to be highly addictive, are routinely prescribed by doctors.
When I was invited to attend the opening of the flagship London clinic last month, where the course costs 7,500, the concept still felt somewhat cloak-and-dagger.
Psychedelics have been around for a long time, but the approach is young and the potential dangers of mind-bending drugs and bad trips are embedded into Western culture.
The clinic space is warm and contemporary. It could be a tech start-up or an independent caf as much as a therapy clinic. The name, Awakn, puts me in mind of the TV series Nine Perfect Strangers, in which Nicole Kidmans mysterious guru character invites struggling guests to her unconventional wellness centre. I suppose we are hard-wired to associate anything related to psychedelics as woo-woo. Certainly, Britons will need to lay down some new neural pathways to get on board.
Scientists such as Nutt and Morgan have long suspected the potential of psychedelics. But theyve found it almost impossible to run trials, even though it has been an area of interest for scientific researchers since the 50s, especially in the US.
Alcoholics Anonymous (AA) co-founder Bill Wilson even intended LSD as the 13th step in the organisations approach to addiction, and credits it for his own recovery. Ultimately, he was ostracised for these views.
Psychoactive plants such as ayahuasca and datura have been used therapeutically by those living close to them for centuries.
Wilson took LSD with the psychologist Betty Eisner and psychiatrist Sidney Cohen. Both were at the forefront of American research into how psychedelics could work alongside talking therapy to treat depression and addiction.
But with the war on drugs in the US came the demonisation and criminalisation of these drugs and practices. Most illegal substances were lumped together, bureaucratically and in the general psyche, as public enemy No 1. Eisner and Cohens work was kneecapped.
It remained legal to use MDMA therapeutically until the mid-80s, when the authorities caught up with its popularity as a party drug. Decades on, Nutt and Morgan seem as surprised as anyone that their work is finally available to the public at large. When had they expected this to happen? They laugh. From Nutt it is more of a guffaw. Never, he replies.
In March, the Royal College of Psychiatrists announced a record 4.1 million referrals to mental health services in 2021, urging the Government to publish a fully funded recovery plan. Awakn, of course, plans to be part of that.
Theres no question places like this are going to be important, says Nutt. The cost burden of severe depression is enormous and clinics like this are going to provide better outcomes at a lower cost.
This is no quick fix though. Theyre not having fun, says Nutt of those who have undergone the treatment. Theyre dealing with the damage theyve done to themselves and their families with alcohol or depression, going back to places where theyve been abused.
I viewed it as work from the outset, confirms Edwards. I think it works on a whole lot of levels. Its great fun in places, it can be very intense in others.
Id gone into it wanting to explore my relationship with my parents and I had the experience of meeting them and was able to clear the air. I wrapped them up in my love and sent them off.
The Awakn programme typically takes place over eight weeks and includes 11 psychotherapy sessions, four ketamine sessions of around two hours each (given by injection) and a final post-course evaluation.
During the ketamine sessions clients are settled under a blanket with music and assisted by a clinical specialist, although it is unusual to talk during thispart.
Psychotherapy sessions follow about 24 hours after the ketamine, when the brain is at its optimum plasticity. This is the time when we are best able to create new ways of thinking.
The ketamine allows users to gain a fresh some call it a fully objective or out of body perspective on their lives and past experiences. The psychotherapy which follows gives them the tools to embed this new outlook into their neural pathways.
Each potential client is assessed individually and will have previously tried other treatments such as antidepressants or substance detoxes. The markers for AUD relate more to how alcohol use is affecting someones life than the volume drunk.
Clients include a photographer who had been drinking three or four beers a night but couldnt stop, a retired civil servant who had struggled with drinking for 40 years and a nurse who didnt want her children to grow up using alcohol as she was.
See the article here:
'I took ketamine to treat my severe depression' - iNews
- Review: Tripping on Utopia Complicates the History of Psychedelics - AOL - March 16th, 2024 [March 16th, 2024]
- Psychedelics Are Going Mainstream. Investing in Them Hasn't. - The Wall Street Journal - January 7th, 2024 [January 7th, 2024]
- Another Study Shows African Psychedelic Plant Ibogaine Treats Traumatic Brain Injury in Vets With 'Dramatic' Results - Good News Network - January 7th, 2024 [January 7th, 2024]
- Massachusetts Lawmakers Will Be Forced To Consider Psychedelics Legalization Measure That Activists Petitioned ... - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA to begin researching psychedelics as treatment option for veterans - Government Executive - January 5th, 2024 [January 5th, 2024]
- VA Is Funding New Research On Psychedelics' Benefits For Veterans With PTSD And Depression - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA ramps up study of psychedelic to treat PTSD - The American Legion - January 5th, 2024 [January 5th, 2024]
- Scientists predict DMT trip from cardiac activity - Big Think - January 5th, 2024 [January 5th, 2024]
- If psychedelics heal, how do they do it? | Proceedings of the National Academy of Sciences - pnas.org - January 5th, 2024 [January 5th, 2024]
- Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential | Molecular ... - Nature.com - January 5th, 2024 [January 5th, 2024]
- U.S. Rep. Correa supports using psychedelics to treat veterans with PTSD - New Santa Ana - January 5th, 2024 [January 5th, 2024]
- DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Psychedelics for Psych Conditions Made Their Mark in 2023 - Medpage Today - January 5th, 2024 [January 5th, 2024]
- 2023: A Good Trip Around the Sun for Psychedelics - The National Law Review - January 5th, 2024 [January 5th, 2024]
- Understanding the Role of the FDA in Advancing Psychedelic Therapy - Medriva - January 5th, 2024 [January 5th, 2024]
- MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics - Psychedelic Alpha - January 5th, 2024 [January 5th, 2024]
- Closing the innovation gap: Advancing psychedelic therapy and medicines in EU mental health care - Open Access Government - January 5th, 2024 [January 5th, 2024]
- The Austin Chronic: SXSW Is High on Psychedelics, as Cannabis Programming Wanes - Austin Chronicle - January 5th, 2024 [January 5th, 2024]
- This Forgotten Psychedelic Could Revolutionize Traumatic Brain Injury Treatment - Inverse - January 5th, 2024 [January 5th, 2024]
- A 'milestone' for psychedelics: Pentagon directed to study alternative treatments for veterans - Washington Times - January 5th, 2024 [January 5th, 2024]
- Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here's What's Next - Singularity Hub - January 5th, 2024 [January 5th, 2024]
- The top 8 psychedelic books you need to read | GreenState - GreenState - January 5th, 2024 [January 5th, 2024]
- Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC - Green Market Report - January 5th, 2024 [January 5th, 2024]
- DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024 - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Here's What You Missed in Cannabis, Psychedelics This Week - TipRanks.com - TipRanks - January 5th, 2024 [January 5th, 2024]
- You're not tripping: State and local leaders give psychedelics another chance - Route Fifty - December 22nd, 2023 [December 22nd, 2023]
- Are Consciousness-Expanding Psychedelics Like Psilocybin More Effective Than Prozac, Zoloft, Xanax, and Other ... - Nautilus - December 22nd, 2023 [December 22nd, 2023]
- RFK, Ramaswamy And Williamson Push Psychedelics Reform On Presidential Campaign Trail - Marijuana Moment - December 22nd, 2023 [December 22nd, 2023]
- Peyote is the darling of the psychedelics renaissance. Indigenous users say it co-opts a sacred way of life - The Guardian US - December 22nd, 2023 [December 22nd, 2023]
- USask researchers explore untold history of psychedelics - News - University of Saskatchewan - USask News - December 22nd, 2023 [December 22nd, 2023]
- California Governor Says Psychedelics Have 'Profound' Healing Potential, But He's Undecided On Legalization Bill As ... - Marijuana Moment - September 25th, 2023 [September 25th, 2023]
- As psychedelic-assisted therapy grows, so does interest from a new group: chaplains - NPR - September 25th, 2023 [September 25th, 2023]
- This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health - Benzinga - September 25th, 2023 [September 25th, 2023]
- Tech Leaders Are Finding Balance Through Microdosing Psychedelics - The Dales Report - September 25th, 2023 [September 25th, 2023]
- Chronic Pain Can Be Treated by Psychedelics, Survey Suggests - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Insights Into the First Psychedelic-Assisted Therapy Guidelines With ... - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Living with long-term cancer is depressing. Texas doctors say psychedelics could help - The Hill - July 19th, 2023 [July 19th, 2023]
- Couples Are Doing MDMA and Ketamine Therapy To Save Their Relationships - VICE - July 19th, 2023 [July 19th, 2023]
- The Way People Are Using Psychedelics Is Changing Amid Reform ... - Marijuana Moment - July 19th, 2023 [July 19th, 2023]
- [WATCH] Turn on, tune in, legalise: Could psychedelics be next in ... - MaltaToday - July 19th, 2023 [July 19th, 2023]
- Will Psychedelics Be Rescheduled After FDA Approval? - Harris Bricken - July 19th, 2023 [July 19th, 2023]
- The Psychedelic Preparedness Scale: A Tool to Optimize Trip ... - Filter - July 19th, 2023 [July 19th, 2023]
- How to Test Psychedelics for Adulterants with Testing Kits - Psychedelic Spotlight - July 19th, 2023 [July 19th, 2023]
- Cannabis Science Conference to debut in Providence, R.I., with ... - GlobeNewswire - July 19th, 2023 [July 19th, 2023]
- New Speaker Rivas weighs in on psychedelics, housing and health care worker minimum wage - Yahoo News - July 19th, 2023 [July 19th, 2023]
- TDR's Top 5 Psychedelic Developments For The Week Of July 10 - The Dales Report - July 19th, 2023 [July 19th, 2023]
- Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ... - February 20th, 2023 [February 20th, 2023]
- Johns Hopkins Launches Center For Psychedelic Research - February 20th, 2023 [February 20th, 2023]
- Psilocybin Treatment for Major Depression Effective for Up to a Year ... - February 20th, 2023 [February 20th, 2023]
- Inside the Johns Hopkins Psilocybin Playlist - Hopkins Medicine - February 20th, 2023 [February 20th, 2023]
- Research Story Tip: Psychedelic Drug Psilocybin Tamps Down Brains Ego ... - February 20th, 2023 [February 20th, 2023]
- Psychedelics: Risks, benefits, and more - Medical News Today - February 18th, 2023 [February 18th, 2023]
- Psychedelic Drug Effects, Side Effects & Dangers - January 25th, 2023 [January 25th, 2023]
- Psychedelics Decriminalization Project In Berkeley, Cal Includes ... - January 6th, 2023 [January 6th, 2023]
- Ancient mummified child was drugged with psychedelics before ritual ... - December 14th, 2022 [December 14th, 2022]
- The therapeutic potential of psychedelics - Science - December 14th, 2022 [December 14th, 2022]
- Changing Lives with Psychedelics: How Connecticut researchers are using magic mushrooms to help people overcome depression, OCD - WTNH.com - November 19th, 2022 [November 19th, 2022]
- Penis Envy Mushroom | Legal Psychedelics | Magic Mushroom - November 7th, 2022 [November 7th, 2022]
- Psychedelics. Discussing natural and synthetic friends. Science, News ... - November 5th, 2022 [November 5th, 2022]
- The Harms of Psychedelics Need to Be Put Into Context - WIRED - November 5th, 2022 [November 5th, 2022]
- Packers' Aaron Rodgers says psychedelics led to his back-to-back MVP ... - October 28th, 2022 [October 28th, 2022]
- With Promise of Legalization, Psychedelic Companies Joust Over Future Profits - The New York Times - October 25th, 2022 [October 25th, 2022]
- How do psychedelics work? This brain region may explain their effects - PBS - October 21st, 2022 [October 21st, 2022]
- Why is the American right suddenly so interested in psychedelic drugs? - The Guardian - October 19th, 2022 [October 19th, 2022]
- Can Psychedelics Cure? Science Is on the Verge of Finding Out - Newsweek - October 19th, 2022 [October 19th, 2022]
- Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development - PsyPost - October 19th, 2022 [October 19th, 2022]
- This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More - Small Pharma - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Made the Mushrooms Magic: Psychedelic Study Explores the Odd Evolution of Mind-Altering Fungi - The Debrief - October 19th, 2022 [October 19th, 2022]
- Psychedelics And Wellness: The Healing Company Buys PepsiCo-Backed Superfoods Company - (HLCO) - Benzinga - October 19th, 2022 [October 19th, 2022]
- What's on the Colorado ballot? Housing, psychedelics, school meals, alcohol, taxes and more | FOX31 Denver - FOX 31 Denver - October 19th, 2022 [October 19th, 2022]
- DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Is Going on With Bright Minds (DRUG) Stock Today? - InvestorPlace - October 19th, 2022 [October 19th, 2022]
- Psychedelics May Ease Fear of Death and Dying - October 17th, 2022 [October 17th, 2022]
- TDR's Top 5 Psychedelic Developments For The Week Of October 10 - The Dales Report - October 17th, 2022 [October 17th, 2022]
- DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023 - Benzinga - October 17th, 2022 [October 17th, 2022]
- Talk set to explore psychedelics and mental health - Reading Today - October 17th, 2022 [October 17th, 2022]
- Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- How does psilocybin rewire the brain? - Open Access Government - October 17th, 2022 [October 17th, 2022]
- HYTN Awarded Controlled Drugs and Substances Dealers License Allowing for Production and Sale of Psilocybin - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands - Yahoo Finance - October 17th, 2022 [October 17th, 2022]